This module uses fundamental data of Infinity Pharmaceuti to approximate its Piotroski F score. Infinity Pharmaceuti F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Infinity Pharmaceuti. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Infinity Pharmaceuti financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Please see Infinity Pharmaceuti Altman Z Score, Infinity Pharmaceuti Correlation, Infinity Pharmaceuti Valuation, as well as analyze Infinity Pharmaceuti Alpha and Beta and Infinity Pharmaceuti Hype Analysis.
Infinity
Piotroski F Score
Net Income Per Employee
Revenue Per Employee
Average Assets
Earnings Before Interest Taxes and Depreciation Amortization EBITDA
Earnings Before Interest Taxes and Depreciation Amortization USD
Earnings before Tax
Average Equity
Enterprise Value
Free Cash Flow
Invested Capital
Invested Capital Average
Market Capitalization
Tangible Asset Value
Working Capital
PPandE Turnover
Accounts Payable Turnover
Accrued Expenses Turnover
Operating Margin
Cash and Equivalents Turnover
Return on Investment
Cash Flow Per Share
Revenue to Assets
Total Assets Per Share
Quick Ratio
Net Current Assets as percentage of Total Assets
Asset Turnover
Book Value per Share
Current Ratio
Debt to Equity Ratio
EBITDA Margin
Earnings per Basic Share
Earnings per Diluted Share
Earnings per Basic Share USD
Enterprise Value over EBIT
Enterprise Value over EBITDA
Free Cash Flow per Share
Profit Margin
Price to Book Value
Price to Earnings Ratio
Price to Sales Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Sales per Share
Tangible Assets Book Value per Share
Capital Expenditure
Depreciation Amortization and Accretion
Net Cash Flow or Change in Cash and Cash Equivalents
Issuance Purchase of Equity Shares
Issuance Repayment of Debt Securities
Net Cash Flow from Financing
Net Cash Flow from Investing
Net Cash Flow Investment Acquisitions and Disposals
Net Cash Flow from Operations
Share Based Compensation
Accounts Payable
Accumulated Other Comprehensive Income
Total Assets
Current Assets
Assets Non Current
Cash and Equivalents
Cash and Equivalents USD
Total Debt
Debt Current
Debt Non Current
Total Debt USD
Deferred Revenue
Shareholders Equity
Shareholders Equity USD
Investments
Investments Current
Investments Non Current
Total Liabilities
Current Liabilities
Liabilities Non Current
Trade and Non Trade Payables
Property Plant and Equipment Net
Trade and Non Trade Receivables
Accumulated Retained Earnings Deficit
Consolidated Income
Earning Before Interest and Taxes EBIT
Earning Before Interest and Taxes USD
Gross Profit
Interest Expense
Net Income
Net Income Common Stock
Net Income Common Stock USD
Operating Expenses
Operating Income
Revenues
Revenues USD
Research and Development Expense
Selling General and Administrative Expense
Weighted Average Shares
Weighted Average Shares Diluted
Income Tax Expense
Probability Of Bankruptcy
Refresh
Infinity Pharmaceuti Debt Non Current is most likely to decrease significantly in the upcoming years. The last year's value of Debt Non Current was reported at 917,000. The current Debt to Equity Ratio is estimated to increase to 3.16, while Issuance Repayment of Debt Securities is projected to decrease to (3.7 M). Infinity Pharmaceuti Accrued Expenses Turnover is most likely to drop in the upcoming years. The last year's value of Accrued Expenses Turnover was reported at 0.27. The current Cash and Equivalents Turnover is estimated to increase to 0.08, while Operating Margin is projected to decrease to (52.31) .
At this time, it appears that Infinity Pharmaceuti's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
The critical factor to consider when applying the Piotroski F Score to Infinity Pharmaceuti is to make sure Infinity is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Infinity Pharmaceuti's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Infinity Pharmaceuti's financial numbers are properly reported.
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Infinity Pharmaceuti's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Infinity Pharmaceuti in a much-optimized way.
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Book Value per Share
0.26
Share
Infinity Pharmaceuti Book Value per Share is most likely to drop slightly in the upcoming years. The last year's value of Book Value per Share was reported at 0.25
Infinity Pharmaceuti Current Valuation Drivers
We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Aroon Oscillator Now
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.
Build Optimal Portfolios
Align your risk with return expectations
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.